Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nilu Perera
Institution:
Royal Brisbane and Women's Hospital
Observed institutions:
The University of Queensland,
Royal Brisbane and Women's Hospital
ORCID:
0000-0002-4752-0551
Observed ORCID:
0000-0002-4752-0551
OpenAlex ID:
A5012624224
Persistent and pathogen-specific infection risk during long-term survivorship after CD19 chimeric antigen receptor T-cell therapy: an Australian multicentre cohort study
2026
·
Gemma K. Reynolds
, Mark R. Dowling
, et al.
·
Clinical Microbiology and Infection
·
2
Dose‐dependent impairment of brain functional and microstructural connectivity during leukaemia chemotherapy
2026
·
Ashleigh P. Scott
, Ada Lo
, et al.
·
British Journal of Haematology
·
2
Granulocyte transfusion supportive care for prolonged cytopenias post CD19 CAR T cell therapy
2024
·
Nilu Perera
, Shoma Baidya
, et al.
·
Transfusion
·
2
PDF
Real-World Outcomes with CD19 CAR T-Cell Therapy for B-Cell Malignancies in Regional/Rural Australia: Results from the Queensland CAR T-Cell Program
2022
·
Nilu Perera
, Ashleigh P Scott
, et al.
·
Blood
·
1
Authors' reply to ‘Comments on dose‐dependent impairment of brain functional and microstructural connectivity during leukaemia chemotherapy’
2026
·
Ashleigh P. Scott
, Ada Lo
, et al.
·
British Journal of Haematology
Multi-centre real-world outcome of patients with Richter transformation receiving CD19-directed commercial CAR T-cell therapy in Australia.
2025
·
Jian Li
, Mark Dowling
, et al.
·
Blood
PDF
Show more works
View as search
Works count:
6
Citation count:
7
H-index:
2
I10-index:
Year
Topic
Type